PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-157 Cr | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-157 Cr |
| Mar2025 | ₹-145 Cr |
| Mar2024 | ₹-157 Cr |
| Mar2023 | ₹-130 Cr |
| Mar2022 | ₹-105 Cr |
How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-157 Cr | Negative | |
| Mar2025 | ₹-145 Cr | Negative | |
| Mar2024 | ₹-157 Cr | Negative | |
| Mar2023 | ₹-130 Cr | Negative | |
| Mar2022 | ₹-105 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹31,132.5 Cr | 0.5% | 18.3% | 18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 0.5% |
18.3% |
18.6% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses